India, May 20 -- image credit- shutterstock

A team of scientists at theInstitute of Advanced Study in Science and Technology (IASST), an autonomous institute of the Department of Science and Technology (DST), has been exploring peptidomimetics, synthetic compounds designed to mimic neurotrophins.

Peptidomimetic drugs - or synthetic molecules that mimic the structure of natural proteins can be repurposed to provide an effective therapeutic strategy to treat neurodegenerative diseases (NDs) by promoting neuronal growth and survival.

Neurotrophin peptidomimetics are developed to target specific biological functions and can be valuable tools in drug discovery, especially when natural peptides have limitations like poor oral bioavailability...